Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new page revision 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' label were removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:18:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.3.1 to v3.3.2, which is a UI/version detail and does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:44.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.3.1 and removes Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:59:17.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A government funding/status notice that previously appeared on the page has been removed; the overall history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:26:10.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    New screenshot shows the same version history entries with only minor visual adjustments to headers and spacing; no core data or version entries were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:01.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 version release, replacing the prior v3.1.0.
    Difference
    10%
    Check dated 2025-10-05T09:35:08.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.